Vaccine Drug-Substance Manufacturing

BE BioSol combines more than 70 years of vaccine-manufacturing experience with established global regulatory and commercial capabilities. Our vaccine drug-substance services include process development, microbial fermentation from 50 L to 4,000 L, downstream recovery and purification, scale-up, technology transfer, analytical testing and process validation. Supported by experienced quality, regulatory and manufacturing teams, we help clients establish robust, reproducible and commercially scalable processes. Biological E.’s proven record of supplying vaccines to more than 130 countries provides partners with a reliable platform for advancing vaccine programs and supporting sustainable global supply.